Divakar Ramakrishnan
Chief Tech/Sci/R&D Officer bei CONVATEC GROUP PLC
Profil
Divakar Ramakrishnan is currently the Director at Companion Medical, Inc. and the Chief Technology Officer & Executive VP at Convatec Group Plc.
Previously, he worked as the Vice President-Manufacturing at Eli Lilly & Co., a Management Consultant at Catalent Indiana LLC, a Senior Scientist at Lilly Research Laboratories, and the SVP-Process Development, Manufacturing & Quality at ModernaTX, Inc. Ramakrishnan holds a doctorate from The Pennsylvania State University, an undergraduate degree from Anna University, and an MBA from Harvard Business School.
Aktive Positionen von Divakar Ramakrishnan
| Unternehmen | Position | Beginn |
|---|---|---|
| CONVATEC GROUP PLC | Chief Tech/Sci/R&D Officer | 01.01.2020 |
Companion Medical, Inc.
 Companion Medical, Inc. Medical SpecialtiesHealth Technology Companion Medical, Inc. develops solutions for diabetes management called InPen. The company was founded by Sean Saint in 2013 and is headquartered in San Diego, CA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Divakar Ramakrishnan
| Unternehmen | Position | Ende |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Chief Tech/Sci/R&D Officer | - |
Catalent Indiana LLC
 Catalent Indiana LLC Pharmaceuticals: MajorHealth Technology Catalent Indiana LLC manufactures biopharmaceutical products. It also manufactures cell culture, recovery and purification, prefilled syringe filling, vial filling and lyophilization, inspection, labeling and packaging. The company was founded in 2004 and is headquartered in Bloomington, IN. | Corporate Officer/Principal | - |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ausbildung von Divakar Ramakrishnan
| The Pennsylvania State University | Doctorate Degree |
| Anna University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CONVATEC GROUP PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Companion Medical, Inc. develops solutions for diabetes management called InPen. The company was founded by Sean Saint in 2013 and is headquartered in San Diego, CA. | Health Technology |
Catalent Indiana LLC
Catalent Indiana LLC Pharmaceuticals: MajorHealth Technology Catalent Indiana LLC manufactures biopharmaceutical products. It also manufactures cell culture, recovery and purification, prefilled syringe filling, vial filling and lyophilization, inspection, labeling and packaging. The company was founded in 2004 and is headquartered in Bloomington, IN. | Health Technology |
Lilly Research Laboratories
Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Health Technology |
